2012-09-17 03:59:13 - Fast Market Research recommends "Leukocyte Disorders (White Blood Cell Disorders) - Pipeline Review, H2 2012" from Global Markets Direct, now available

Global Markets Direct's, 'Leukocyte Disorders (White Blood Cell Disorders) - Pipeline Review, H2 2012', provides an overview of the Leukocyte Disorders (White Blood Cell Disorders) therapeutic pipeline. This report provides information on the therapeutic development for Leukocyte Disorders (White Blood Cell Disorders), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Leukocyte Disorders (White Blood Cell Disorders). 'Leukocyte Disorders (White Blood Cell Disorders) - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.


Full

Report Details at
- www.fastmr.com/prod/463894_leukocyte_disorders_white_blood_cell_ ..


Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Leukocyte Disorders (White Blood Cell Disorders).
* A review of the Leukocyte Disorders (White Blood Cell Disorders) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Leukocyte Disorders (White Blood Cell Disorders) pipeline on the basis of route of administration and molecule type.
* Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Leukocyte Disorders (White Blood Cell Disorders).
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Leukocyte Disorders (White Blood Cell Disorders) pipeline depth and focus of Leukocyte Disorders (White Blood Cell Disorders) therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Keywords

Leukocyte Disorders (White Blood Cell Disorders) Therapeutic Products under Development, Key Players in Leukocyte Disorders (White Blood Cell Disorders) Therapeutics, Leukocyte Disorders (White Blood Cell Disorders) Pipeline Overview, Leukocyte Disorders (White Blood Cell Disorders) Pipeline, Leukocyte Disorders (White Blood Cell Disorders) Pipeline Assessment

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Leukocyte Disorders (White Blood Cell Disorders) Overview
Therapeutics Development
An Overview of Pipeline Products for Leukocyte Disorders (White Blood Cell Disorders)
Leukocyte Disorders (White Blood Cell Disorders) Therapeutics under Development by Companies
Leukocyte Disorders (White Blood Cell Disorders) Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Leukocyte Disorders (White Blood Cell Disorders) Therapeutics - Products under Development by Companies
Leukocyte Disorders (White Blood Cell Disorders) Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Leukocyte Disorders (White Blood Cell Disorders) Therapeutics Development
Kyowa Hakko Kirin Co., Ltd.
GlaxoSmithKline plc
Gamida Cell Ltd.
Mochida Pharmaceutical Co., Ltd.
STADA Arzneimittel AG
Taiho Pharmaceutical Co., Ltd.
Ligand Pharmaceuticals Incorporated
Lupin Limited
NexMed, Inc.
Telik, Inc.
Zenotech Laboratories Limited
ProMetic Life Sciences Inc.
Lipoxen PLC
Green Cross Corporation
Bolder Biotechnology, Inc.
Welichem Biotech Inc.
PharmaEssentia Corporation
ImmuneRegen BioSciences, Inc.
Pfenex Inc.
Leukocyte Disorders (White Blood Cell Disorders) - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
Homspera - Drug Profile
Telintra - Drug Profile
P1130 - Drug Profile
WBI-2100 - Drug Profile
StimuXen - Drug Profile
GCPGC - Drug Profile
CordBridge - Drug Profile
MK-0991 - Drug Profile
KRN125 - Drug Profile
KRN125 - Drug Profile
Daptomycin - Drug Profile
Imatinib Mesylate - Drug Profile
Alemtuzumab + Busulfan + Cyclosporine + Fludarabine + Methotrexate + Methylprednisolone + Filgrastim + Stem Cell Transplantation - Drug Profile

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=463894&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.